Together, these results demonstrate the protective role of Smarca5 in regulating erythrocyte homeostasis and that the smarca5 loss-of-function zebrafish mutant may serve as a new thrombosis model to screen molecular drugs for clinical therapy. This evidence concerns the gene SMARCA5 and deep vein thrombosis.